Frederick M. Miesowicz

Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC.

Part of Jazz Pharmaceuticals Plc, Cellcor, Inc. is a company that specializes in the development of cellular therapies. The company is based in Newton, MA. Cellcor was acquired by Jazz Pharmaceuticals (EUSA Pharma USA), Inc., part of Jazz Pharmaceuticals Plc from May 09, 2008 on October 23, 1995 for $20 million.

Terumo Medical Corp. manufactures and distributes medical products. It offers products through three business divisions: Terumo Interventional Systems, Terumo Medical Products, and Terumo Transfusion Products. The company was founded in 1972 and is based in Somerset, NJ.

DuPont de Nemours (Luxembourg) SARL manufactures synthetic resins, synthetic rubbers and industrial chemicals. It offers services to markets, such as agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation, and apparel. The company was founded in 1962 and is headquartered in Luxembourg.